Program Director/Principal Investigator (Last, First, Middle): El-Sadr, Wafaa M. Project Summary The HIV epidemic continues to rage uncontained in many countries around the world, particularly in sub Saharan Africa. Lesotho, a small country in Southern Africa, has been severely affected with an estimated HIV seroprevalence of 23% among adults, the third highest rate in the world. Discordant couples for HIV where one partner is HIV infected and the other HIV negative represent a situation where the HIV negative partner is at high risk for acquiring HIV. Such transmission within married or cohabitating couples has been recognized as a major contributor to the spread of HIV. Thus, effective interventions that aim at prevention of transmission within HIV sero-discordant heterosexual couples are likely to have an important public health impact. We propose an innovative clinical trial, the Enhanced Prevention in Couples Study (EPIC Study), that aims at evaluating the effect of Enhanced Prevention Package (EPP) versus Standard of Care (SOC) on risk of HIV acquisition in HIV negative partners within HIV discordant couples enrolled from antenatal clinics (ANCs) in Lesotho. The Enhanced Prevention Package will include the following interventions: 1) antiretroviral therapy (ART) for the HIV infected partners at threshold of <500 CD4 cell count, 2) couple-focused counseling for decreasing sexual risk behavior and enhancing adherence with ART, and 3) circumcision for HIV negative male partners. The goals of this application are as follows: A. To describe the design of the EPIC study which will assess an Enhanced Prevention Package inclusive of biomedical and behavioral interventions through a randomized controlled trial. B. To conduct feasibility and acceptability studies of key components of the Enhanced Prevention Package in the form of three focused studies: 1) assessment of strategies for recruitment and HIV testing of male partners of women participating in ANCs, 2) determination of feasibility of couple-focused counseling for sexual risk reduction and ART adherence and 3) evaluation of acceptability of male circumcision. C. To model the potential effect of the Enhanced Prevention Package in terms of its effect on HIV transmission in Lesotho. D. To utilize the findings from the three studies, the results of the modeling and information garnered from the literature and from programs in Lesotho in refining the design of EPIC study The team of investigators involved in this application includes a diversity of expertise and a wealth of experience. They include epidemiologists, behavioral scientists, clinical researchers, program implementers as well as modeling and statistical experts. They are partnering with collaborators in Lesotho in the planning of this research. They have extensive experience in establishing programs in sub Saharan Africa and have successfully designed and implemented prevention studies in diverse settings.

Public Health Relevance

El-Sadr, Wafaa M. Relevance The HIV epidemic continues to spread in sub-Saharan Africa with Lesotho, a country is Southern Africa, one of the most severely affected countries. There is an urgent need for identification of effective HIV prevention strategies that could stem the epidemic. We propose an innovative study, the Enhanced Prevention in Couples (EPIC) Study, to evaluate a multi-component prevention package in HIV discordant couples in Lesotho, a group at substantial risk of HIV transmission. Feasibility and acceptability studies as well as modeling exercises will inform the design of the ultimate study and determine its potential public health impact. PHS 398/2590 (Rev. 11/07) Page 1 Continuation Format Page

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI083038-02
Application #
7860625
Study Section
Special Emphasis Panel (ZAI1-GPJ-A (J1))
Program Officer
Elharrar, Vanessa
Project Start
2009-06-08
Project End
2013-05-31
Budget Start
2010-06-01
Budget End
2011-05-31
Support Year
2
Fiscal Year
2010
Total Cost
$1,444,945
Indirect Cost
Name
Columbia University (N.Y.)
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
DiCarlo, Abby; Zerbe, Allison; Peters, Zachary J et al. (2017) Use of Index Patients to Enable Home-Based Testing in Lesotho. J Acquir Immune Defic Syndr 76:e61-e64
Mantell, J E; DiCarlo, A L; Remien, R H et al. (2014) 'There's no place like home': perceptions of home-based HIV testing in Lesotho. Health Educ Res 29:456-69
DiCarlo, Abby L; Mantell, Joanne E; Remien, Robert H et al. (2014) 'Men usually say that HIV testing is for women': gender dynamics and perceptions of HIV testing in Lesotho. Cult Health Sex 16:867-82
Paredes, Roger; Marconi, Vincent C; Lockman, Shahin et al. (2013) Impact of antiretroviral drugs in pregnant women and their children in Africa: HIV resistance and treatment outcomes. J Infect Dis 207 Suppl 2:S93-100
Coburn, Brian J; Okano, Justin T; Blower, Sally (2013) Current drivers and geographic patterns of HIV in Lesotho: implications for treatment and prevention in Sub-Saharan Africa. BMC Med 11:224
Coburn, Brian J; Blower, Sally (2012) A feasibility analysis of implementing interventions for discordant couples in 14 African countries: implications for epidemic control. AIDS 26:1969-71
Go, Myong-Hyun; Blower, Sally (2012) What impact will reducing concurrency have on decreasing the incidence of HIV in heterosexual populations? Sex Transm Dis 39:414-5
Selby, Van N; Scherzer, Rebecca; Barnett, Christopher F et al. (2012) Doppler echocardiography does not accurately estimate pulmonary artery systolic pressure in HIV-infected patients. AIDS 26:1967-9
El-Sadr, Wafaa M; Coburn, Brian J; Blower, Sally (2011) Modeling the impact on the HIV epidemic of treating discordant couples with antiretrovirals to prevent transmission. AIDS 25:2295-9
Rabkin, Miriam; El-Sadr, Wafaa M; Mugyenyi, Peter et al. (2010) Lessons from Africa. J Acquir Immune Defic Syndr 55 Suppl 2:S141-3